Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx)
Recruiting
N/A
Interventional Study
Type 2 Diabetes Mellitus (T2DM)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 500 (estimated)
- Sponsor
- EVYD Technology · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 to 70 years
* Diagnosed with T2DM who are on any one or more of the following treatments:
1. oral glucose lowering medication(s)
2. any type of insulin treatment (up to 2 injections a day only)
3. on diet control only
4. GLP-1 receptor agonist established at le…
Contacts